EXPOSE: DEA’s Marijuana Licensing Scheme Exposed – MMJ BioPharma’s Case Reveals DEA Contradiction Blocking FDA Approved Cannabis Medicine
Newly uncovered DEA agreements confirm what MMJ BioPharma Cultivation has argued for years – that the agency’s own rules make it impossible for any company to legally produce pharmaceutical grade cannabis for FDA authorized clinical research. WASHINGTON, D.C. / ACCESS Newswire / October 26, 2025 / A recently disclosed memorandum of understanding between the DEA […]